REPLIGEN CORP acquires C Technologies, Inc.
The deal at a glance
REPLIGEN CORP acquired C Technologies, Inc. for ~$240 million ($192M cash + $48M in Repligen stock), a transaction completed in May 2019, structured as combination (cash plus stock).
C Technologies, Inc. operates in Process Analytics, is based in Bridgewater, New Jersey, USA, had revenue of about ~$16-$17 million projected annual revenue contribution. Acquisition of privately held C Technologies, Inc., maker of the SoloVPE and FlowVPE Slope Spectroscopy systems for real-time protein concentration measurement, establishing Repligen's Process Analytics franchise. Projected to contribute ~$16-$17 million in revenue.
Hunt said 'the addition of C Technologies is a major step forward in building out a Process Analytics franchise for Repligen,' with plans to develop the core Slope Spectroscopy technology for real-time bioprocess applications.
Differentiated real-time PAT technology with strong growth. Founded a new Process Analytics franchise alongside filtration/chromatography/proteins. Repligen Process Analytics franchise
No advisory firms have been disclosed for this transaction.